CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor 165 in Ewing sarcoma cells

45Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: TC-71 Ewing sarcoma cells overexpress vascular endothelial growth factor (VEGF) with a shift from the 189 to the 165 isoform. Methods: The effect of CAPER-α on the expression of the VEGF isoforms, tumor growth, and vessel density was analyzed after transfection of TC-71 cells with CAPER-α cDNA or siRNA. Results: CAPER-α correlated inversely with the VEGF 165/VEGF 189 mRNA ratio. Up-regulation of CAPER-α resulted in decreased tumor growth, tumor vessel density, and chemotactic activity of the cell's supernatant. CAPER-α expression was regulated by EWS/FLI-1 through a protein-protein interaction. Conclusions: Increased VEGF 165 expression is secondary to the down-regulation of CAPER-α by EWS/FLI-1. CAPER-α mediates alternative splicing and controls the shift from VEGF 189 to VEGF 165. © 2011 American Cancer Society.

Cite

CITATION STYLE

APA

Huang, G., Zhou, Z., Wang, H., & Kleinerman, E. S. (2012). CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor 165 in Ewing sarcoma cells. Cancer, 118(8), 2106–2116. https://doi.org/10.1002/cncr.26488

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free